These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20712794)

  • 1. Pulmonary hypertension in thalassemia.
    Morris CR; Vichinsky EP
    Ann N Y Acad Sci; 2010 Aug; 1202():205-13. PubMed ID: 20712794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemolysis-associated pulmonary hypertension in thalassemia.
    Morris CR; Kuypers FA; Kato GJ; Lavrisha L; Larkin S; Singer T; Vichinsky EP
    Ann N Y Acad Sci; 2005; 1054():481-5. PubMed ID: 16339702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The natural history of thalassemia intermedia.
    Borgna-Pignatti C; Marsella M; Zanforlin N
    Ann N Y Acad Sci; 2010 Aug; 1202():214-20. PubMed ID: 20712795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine deaminase-adenosine pathway in hemolysis-associated pulmonary hypertension.
    Tofovic SP; Jackson EK; Rafikova O
    Med Hypotheses; 2009 Jun; 72(6):713-9. PubMed ID: 19237250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state.
    Singer ST; Kuypers FA; Styles L; Vichinsky EP; Foote D; Rosenfeld H
    Am J Hematol; 2006 Sep; 81(9):670-5. PubMed ID: 16795058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?
    Morris CR; Morris SM; Hagar W; Van Warmerdam J; Claster S; Kepka-Lenhart D; Machado L; Kuypers FA; Vichinsky EP
    Am J Respir Crit Care Med; 2003 Jul; 168(1):63-9. PubMed ID: 12626350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary hypertension in sickle cell disease.
    Lee MT; Rosenzweig EB; Cairo MS
    Clin Adv Hematol Oncol; 2007 Aug; 5(8):645-53, 585. PubMed ID: 17982405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemia.
    Morris CR; Kim HY; Klings ES; Wood J; Porter JB; Trachtenberg F; Sweeters N; Olivieri NF; Kwiatkowski JL; Virzi L; Hassell K; Taher A; Neufeld EJ; Thompson AA; Larkin S; Suh JH; Vichinsky EP; Kuypers FA;
    Br J Haematol; 2015 Jun; 169(6):887-98. PubMed ID: 25907665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet aggregation in arterial hypertension: is there a nitric oxide-urea connection?
    Moss MB; Siqueira MA; Mann GE; Brunini TM; Mendes-Ribeiro AC
    Clin Exp Pharmacol Physiol; 2010 Feb; 37(2):167-72. PubMed ID: 19566824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sickle cell anemia and vascular dysfunction: the nitric oxide connection.
    Akinsheye I; Klings ES
    J Cell Physiol; 2010 Sep; 224(3):620-5. PubMed ID: 20578237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of vasculopathy in sickle cell disease and thalassemia.
    Morris CR
    Hematology Am Soc Hematol Educ Program; 2008; ():177-85. PubMed ID: 19074078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric assessment of circulating platelet and erythrocytes microparticles in young thalassemia major patients: relation to pulmonary hypertension and aortic wall stiffness.
    Tantawy AA; Adly AA; Ismail EA; Habeeb NM
    Eur J Haematol; 2013 Jun; 90(6):508-18. PubMed ID: 23506251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal natriuretic peptide and ventilation-perfusion lung scan in sickle cell disease and thalassemia patients with pulmonary hypertension.
    Mokhtar GM; Adly AA; El Alfy MS; Tawfik LM; Khairy AT
    Hemoglobin; 2010; 34(1):78-94. PubMed ID: 20113292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procedure-related pulmonary hypertension in patients with hepatocellular carcinoma undergoing percutaneous ethanol injection--role of ethanol, hemolysis, asymmetric dimethylarginine, and the nitric oxide system.
    Kielstein JT; Hesse G; Bahr MJ; Tsikas D; Terkamp C; Martens-Lobenhoffer J; Manns MP; Haller H; Panning B; Bode-Böger SM; Gebel M
    Crit Care Med; 2009 Apr; 37(4):1483-5. PubMed ID: 19242353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical indicators for pulmonary arterial hypertension in thalassemia.
    Chueamuangphan N; Wongtheptien W; Nawarawong W; Sukornthasarn A; Chuncharunee S; Tawichasri C; Patumanond J
    J Med Assoc Thai; 2012 Jan; 95(1):16-21. PubMed ID: 22379736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pulmonary hypertension in patient with beta-thalassemia major].
    Mérault JM; Escamilla R; Degano B; Guittard J; Hermant C; Krempf M
    Rev Mal Respir; 2000 Jun; 17(3):689-91. PubMed ID: 10951965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for pulmonary hypertension in patients with thalassemia intermedia.
    Amoozgar H; Farhani N; Karimi M
    Eur J Haematol; 2010 Dec; 85(6):549-51. PubMed ID: 20698879
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathways to pulmonary hypertension in sickle cell disease: the search for prevention and early intervention.
    Shilo NR; Morris CR
    Expert Rev Hematol; 2017 Oct; 10(10):875-890. PubMed ID: 28817980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disorders.
    Morris CR; Gladwin MT; Kato GJ
    Curr Mol Med; 2008 Nov; 8(7):620-32. PubMed ID: 18991648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary hypertension associated with thalassemia syndromes.
    Fraidenburg DR; Machado RF
    Ann N Y Acad Sci; 2016 Mar; 1368(1):127-39. PubMed ID: 27008311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.